BRPI0509140A - processos para o tratamento de infecção por hiv - Google Patents

processos para o tratamento de infecção por hiv

Info

Publication number
BRPI0509140A
BRPI0509140A BRPI0509140-3A BRPI0509140A BRPI0509140A BR PI0509140 A BRPI0509140 A BR PI0509140A BR PI0509140 A BRPI0509140 A BR PI0509140A BR PI0509140 A BRPI0509140 A BR PI0509140A
Authority
BR
Brazil
Prior art keywords
hiv infection
processes
treating hiv
treating
aids
Prior art date
Application number
BRPI0509140-3A
Other languages
English (en)
Inventor
Pin-Fang Lin
Beata Nowicka-Sans
Gregory Yamanaka
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0509140(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BRPI0509140A publication Critical patent/BRPI0509140A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"PROCESSOS PARA O TRATAMENTO DE INFECçãO POR HIV. A invenção refere-se composições farmacêuticas e a processos para a utilização do Composto 1 Tradução: Composto 1 em combinação com outros agentes para o tratamento de pacientes com AIDS ou com infecção por HIV.
BRPI0509140-3A 2004-03-24 2005-03-01 processos para o tratamento de infecção por hiv BRPI0509140A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55576704P 2004-03-24 2004-03-24
PCT/US2005/006277 WO2005102392A2 (en) 2004-03-24 2005-03-01 Combinations for treating hiv infection

Publications (1)

Publication Number Publication Date
BRPI0509140A true BRPI0509140A (pt) 2007-09-04

Family

ID=34961940

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509140-3A BRPI0509140A (pt) 2004-03-24 2005-03-01 processos para o tratamento de infecção por hiv

Country Status (31)

Country Link
US (1) US7776863B2 (pt)
EP (1) EP1732604B1 (pt)
JP (1) JP4847441B2 (pt)
KR (1) KR101158140B1 (pt)
CN (1) CN1956720B (pt)
AR (1) AR048333A1 (pt)
AT (1) ATE474602T1 (pt)
AU (1) AU2005235116B2 (pt)
BR (1) BRPI0509140A (pt)
CA (1) CA2561146C (pt)
CY (1) CY1111613T1 (pt)
DE (1) DE602005022420D1 (pt)
DK (1) DK1732604T3 (pt)
ES (1) ES2347801T3 (pt)
GE (1) GEP20104925B (pt)
HK (1) HK1096540A1 (pt)
HR (1) HRP20100434T1 (pt)
IL (1) IL178141A (pt)
IN (1) IN2012DN06436A (pt)
MY (1) MY144318A (pt)
NO (1) NO337116B1 (pt)
NZ (1) NZ549778A (pt)
PE (1) PE20060148A1 (pt)
PL (1) PL1732604T3 (pt)
PT (1) PT1732604E (pt)
RU (1) RU2367439C2 (pt)
SI (1) SI1732604T1 (pt)
TW (1) TWI347184B (pt)
UA (1) UA88463C2 (pt)
WO (1) WO2005102392A2 (pt)
ZA (1) ZA200607959B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
JP5251127B2 (ja) 2005-10-28 2013-07-31 小野薬品工業株式会社 塩基性基を含有する化合物およびその用途
EP1961744B1 (en) 2005-11-18 2013-04-17 Ono Pharmaceutical Co., Ltd. Basic group-containing compound and use thereof
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7501419B2 (en) * 2006-04-25 2009-03-10 Bristol-Myers Squibb Company 4-Squarylpiperazine derivatives as antiviral agents
US7807671B2 (en) * 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7504399B2 (en) 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
US7572810B2 (en) * 2006-06-08 2009-08-11 Bristol-Myers Squibb Company Alkene piperidine derivatives as antiviral agents
CN102076686B (zh) * 2008-06-25 2013-03-06 百时美施贵宝公司 作为hiv附着抑制剂的二酮哌啶衍生物
WO2009158394A1 (en) 2008-06-25 2009-12-30 Bristol-Myers Squibb Company Diketo azolopiperidines and azolopiperazines as anti-hiv agents
US20110290821A1 (en) * 2010-05-28 2011-12-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-viral compositions and methods for administration
EP2601174B1 (en) 2010-08-06 2014-11-26 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
ES2585396T3 (es) 2010-12-02 2016-10-05 VIIV Healthcare UK (No.5) Limited Alquilamidas como inhibidores de la unión del VIH
DK2670751T3 (en) 2011-01-31 2015-07-20 Bristol Myers Squibb Co PROCEDURES FOR MANUFACTURING HIV BINDING INHIBITOR PRODUCT CONNECTION AND INTERMEDIATES
EP2696937B1 (en) 2011-04-12 2017-05-17 VIIV Healthcare UK (No.5) Limited Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
ES2616268T3 (es) 2011-08-29 2017-06-12 VIIV Healthcare UK (No.5) Limited Derivados condensados de diamina bicíclica como inhibidores de la unión de VIH
WO2013033059A1 (en) 2011-08-29 2013-03-07 Bristol-Myers Squibb Company Spiro bicyclic diamine derivatives as hiv attachment inhibitors
WO2013138436A1 (en) 2012-03-14 2013-09-19 Bristol-Myers Squibb Company Cyclolic hydrazine derivatives as hiv attachment inhibitors
US9655888B2 (en) 2012-08-09 2017-05-23 VIIV Healthcare UK (No.5) Limited Tricyclic alkene derivatives as HIV attachment inhibitors
EP2895471B1 (en) 2012-08-09 2016-11-23 VIIV Healthcare UK (No.5) Limited Piperidine amide derivatives as hiv attachment inhibitors
ES2667822T3 (es) * 2013-03-27 2018-05-14 VIIV Healthcare UK (No.5) Limited Derivados de 2-ceto amida como inhibidores de fijación a VIH
CA2988650A1 (en) * 2015-06-23 2016-12-29 Cytodyn Inc. Inhibition of ccl5 ligand binding to ccr5 receptor and alteration of ccr5/ccl5 axis signaling in inflammation, cancer, autoimmune, and other conditions
WO2023172635A1 (en) * 2022-03-08 2023-09-14 Emory University Predictive model for variants associated with drug resistance and theranostic applications thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2281960T3 (es) * 1998-03-02 2007-10-01 The University Of North Carolina At Chapel Hill Derivados acilados de betulina y dihidrobetulina, su preparacion y su uso.
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20030207910A1 (en) 2001-02-02 2003-11-06 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
IL162325A0 (en) * 2001-12-12 2005-11-20 Bristol Myers Squibb Co Hiv integrase inhibitor compounds and pharmaceutical compositions containing the same
US20030220341A1 (en) * 2001-12-21 2003-11-27 Gary Bridger Chemokine receptor binding heterocyclic compounds with enhanced efficacy

Also Published As

Publication number Publication date
WO2005102392A3 (en) 2006-07-20
US20050215545A1 (en) 2005-09-29
KR101158140B1 (ko) 2012-06-19
MY144318A (en) 2011-08-29
CA2561146A1 (en) 2005-11-03
PL1732604T3 (pl) 2010-12-31
UA88463C2 (ru) 2009-10-26
IL178141A (en) 2010-11-30
AU2005235116A1 (en) 2005-11-03
AU2005235116B2 (en) 2011-03-31
ES2347801T3 (es) 2010-11-04
KR20070011322A (ko) 2007-01-24
SI1732604T1 (sl) 2010-10-29
TWI347184B (en) 2011-08-21
HRP20100434T1 (hr) 2010-09-30
JP2007530540A (ja) 2007-11-01
RU2367439C2 (ru) 2009-09-20
TW200538117A (en) 2005-12-01
ATE474602T1 (de) 2010-08-15
IL178141A0 (en) 2006-12-31
JP4847441B2 (ja) 2011-12-28
CN1956720A (zh) 2007-05-02
EP1732604A2 (en) 2006-12-20
NO337116B1 (no) 2016-01-25
EP1732604B1 (en) 2010-07-21
DE602005022420D1 (de) 2010-09-02
PE20060148A1 (es) 2006-03-04
NO20064547L (no) 2006-10-06
HK1096540A1 (en) 2007-06-01
GEP20104925B (en) 2010-03-25
NZ549778A (en) 2010-09-30
PT1732604E (pt) 2010-09-24
CY1111613T1 (el) 2015-10-07
CN1956720B (zh) 2010-12-15
ZA200607959B (en) 2008-06-25
WO2005102392A2 (en) 2005-11-03
US7776863B2 (en) 2010-08-17
IN2012DN06436A (pt) 2015-10-09
CA2561146C (en) 2013-12-24
AR048333A1 (es) 2006-04-19
RU2006137555A (ru) 2008-04-27
DK1732604T3 (da) 2010-11-15

Similar Documents

Publication Publication Date Title
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
WO2006034001A3 (en) Methods of treating hiv infection
BRPI0612309B8 (pt) compostos e composições farmacêuticas antivirais
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
ES2616789T8 (es) Inhibidores de tirosina cinasa de Bruton
MA34002B1 (fr) Thérapie antivirale
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
RS51069B (sr) Upotreba oksikodona za tretiranje visceralnog bola
TW200510343A (en) Substituted dihydroquinazolines
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
IL178094A0 (en) Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
BR0317539A (pt) Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais
WO2005023270A3 (en) Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors
ATE532509T1 (de) Mittel zur hemmung des eintritts des hiv-virus
ATE458750T1 (de) Antivirale mittel zur behandlung, kontrolle und prävention von infektionen durch coronaviren
BRPI0413132A (pt) composições e compostos bicìclicos como inibidores de pdf
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
BRPI0409586A (pt) ácidos hidroxámicos úteis no tratamento de distúrbios hiperproliferativos
DE502006004735D1 (de) Mittel zur behandlung von infektionen

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: VIIV HEALTHCARE UK (NO.4) LIMITED (GB)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL